PNPLA3 and metabolic dysfunction-associated steatotic liver disease: In past research, the PNPLA3 I148M (tSNP rs738409) polymorphism has been associated with loss of the protein’s hydrolyzing function and triglyceride accumulation [12], which appears to confer greater susceptibility to NAFLD [16], [17].